Home › Funds › Amova Asset Management Americas, Inc. › TWST

Amova Asset Management Americas, Inc. position in TWST

TWIST BIOSCIENCE CORP · Health Care

Amova Asset Management Americas, Inc. reported holding 776,099 shares of TWST (TWIST BIOSCIENCE CORP) in its Q3 2026 13F filing — a position valued at US$149.8M, representing 1.86% of its reported portfolio and ranking #15 among its reported holdings. Amova Asset Management Americas, Inc. has disclosed TWST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)776.10K sh
Reported value held$149.81M
Portfolio Weight1.86%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Amova Asset Management Americas, Inc.'s TWST position evolved

Amova Asset Management Americas, Inc. first disclosed a stake in TWST in Q3 2023 at 3,483,932 shares (US$70.4M). The position peaked in Q2 2024 at 3,163,431 shares, worth US$155.9M. Across 13 filings, Amova Asset Management Americas, Inc. increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 776,099 shares valued at US$149.8M — a reduction of -223,635 shares quarter over quarter.. Notable position changes include a 33% trim in Q2 2026 (shares rose 88% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.48M $70.45M New
Q4 2023 3.58M $131.83M Add
Q1 2024 3.55M $121.67M Reduce
Q2 2024 3.16M $155.86M Reduce
Q3 2024 2.86M $129.22M Reduce
Q4 2024 2.61M $121.37M Reduce
Q1 2025 2.42M $94.80M Reduce
Q2 2025 2.30M $84.50M Reduce
Q3 2025 2.12M $59.64M Reduce
Q4 2025 1.90M $60.26M Reduce
Q1 2026 1.50M $71.09M Reduce
Q2 2026 999.73K $102.84M Reduce
Q3 2026 776.10K $149.81M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TWST and 13F data

TWST (TWIST BIOSCIENCE CORP) is a Health Care company. 62 other funds we track also report a position in TWST — the largest reported positions include ARK Invest (US$656.6M), Artisan Partners Limited Partnership (US$395.1M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$281.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TWST

All TWST fund holders →

FAQ

How long has Amova Asset Management Americas, Inc. held TWST?

Amova Asset Management Americas, Inc. has disclosed TWST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Amova Asset Management Americas, Inc.'s current position in TWST?

As of Q3 2026, Amova Asset Management Americas, Inc. holds 776.10K shares of TWST (TWIST BIOSCIENCE CORP), valued at $149.81M, representing 1.86% of its reported portfolio and ranking #15.

Has Amova Asset Management Americas, Inc. been buying or selling TWST?

In the latest 13F filing (Q3 2026), Amova Asset Management Americas, Inc. reduced its position in TWST. The position peaked in Q2 2024 at 3.16M shares.

Which other funds hold TWST?

Other major institutional holders of TWST include ARK Invest, Artisan Partners Limited Partnership, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.